|
MechanismIL2RA inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shanghai Guojian Biotechnology Research Institute
0 Patents (Medical) associated with Shanghai Guojian Biotechnology Research Institute
100 Deals associated with Shanghai Guojian Biotechnology Research Institute
100 Translational Medicine associated with Shanghai Guojian Biotechnology Research Institute